American Portfolios Advisors - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2022$4,270
-8.2%
1,0000.0%0.00%
Q4 2021$4,650
-22.3%
1,000
-33.3%
0.00%
Q3 2021$5,985
-6.8%
1,5000.0%0.00%
Q2 2021$6,420
+0.9%
1,5000.0%0.00%
Q1 2021$6,360
+9.3%
1,5000.0%0.00%
Q4 2020$5,820
-50.2%
1,500
-48.3%
0.00%
-100.0%
Q3 2020$11,687
-33.1%
2,900
-29.3%
0.00%0.0%
Q2 2020$17,4664,1000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$110,713,00017.54%
Consonance Capital Management LP 2,079,311$66,912,0006.04%
RTW INVESTMENTS, LP 1,063,170$34,213,0005.71%
Broadfin Capital, LLC 1,029,866$33,141,0005.42%
Perceptive Advisors 3,388,611$109,046,0003.62%
SECTORAL ASSET MANAGEMENT INC 854,301$27,491,0003.44%
Boxer Capital, LLC 267,500$8,608,0001.57%
Ghost Tree Capital, LLC 200,000$6,436,0001.51%
EMORY UNIVERSITY 51,632$1,662,0001.43%
Stanley-Laman Group, Ltd. 168,653$5,427,0001.17%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders